Hepatitis C
Dual Pandemics – What Will COVID-19 Mean for Hepatitis C Elimination?
Australia is a world leader in its efforts to eliminate hepatitis C and to improve the health of people who use drugs. But COVID-19, on a backdrop of economic uncertainty, anxiety and unemployment has the potential to disrupt our support, prevention and cure efforts – especially given the populations most impacted by hepatitis C and drug dependence are some of our most vulnerable Australians.
9th International Conference on Hepatitis Care in Substance Users
The 9th International Conference on Hepatitis Care in Substance Users will be held in Glasgow, Scotland, 8 – 10 October 2020.
Hepatitis C New Models of Care for Drugs Services
8th International Conference on Hepatitis Care in Substance Users
The 8th INHSU conference covers the latest advances on hepatitis C epidemiology, management and
Information and Advice for the Families of People Living with Hepatitis C
Drug Misuse and Hepatitis C Virus Infection Profiles for Three Generations of Patients Being Monitored for Prescription Drug Adherence
Beyond Cure: Patient Reported Outcomes of Hepatitis C Treatment among People who Inject Drugs in Australia
2018 European African HIV/AIDS & Hepatitis C Community Summit
The 2018 European African HIV/AIDS & Hepatitis C Community Summit will take place in Amsterdam from 21-22nd July 2018.
Coordinated by the European African Treatment Advocates Network (ETAN) the event aims to work towards improved connection with immigrants in Europe to treat and prevent HIV and Hepatitis C.